Picture of Arcadia Biosciences logo

RKDA Arcadia Biosciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapValue Trap

Annual cashflow statement for Arcadia Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.1-15.6-14-7.04-2.34
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-6.521.041.91-1.26-2.41
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.260.118-3.51-1.45-0.026
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-25.9-14-15.3-9.63-4.74
Capital Expenditures-1.01-0.072-0.005-0.0160
Purchase of Fixed Assets
Other Investing Cash Flow Items17.61.49-4.347.360.75
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities16.61.42-4.347.340.75
Financing Cash Flow Items-1.16-0.488-0.497
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities21.94.525.510.0090.006
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash12.6-8.04-14.1-2.28-3.98